AB

Akash Bhatnagar

Active Director Additional Director DIN 11244961
DIN 11244961 First appointment Aug 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Akash Bhatnagar

Data last updated:

Akash Bhatnagar is an Additional Director at Pharmaref International Private Limited (since 2025). The company operates in Healthcare.

DIN 11244961
Primary Designation Additional Director
Industry Healthcare
First Appointment 22 Aug 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director22 Aug 2025Active

Board colleagues of Akash Bhatnagar

Directorship timeline

Open interactive timeline →
Pharmaref International Private Limited
Premium access

Shareholding and investment profile for Akash Bhatnagar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Akash Bhatnagar

Akash Bhatnagar currently holds 1 directorship: Pharmaref International Private Limited (Additional Director, since 22 Aug 2025).

Akash Bhatnagar was first appointed on 22 Aug 2025 as Additional Director at Pharmaref International Private Limited.

The current boards of Akash Bhatnagar's companies include Prateek Ajmera (Pharmaref International Private Limited), Stanley David Burhans (Pharmaref International Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available